Research Article
Neutrophil-to-Lymphocyte Ratio (NLR) Predicts PD-1 Inhibitor Survival in Patients with Metastatic Gastric Cancer
Table 2
Treatment response in the
group and in the
group.
| Response | | | value | | % | | % |
| No. patients | 81 | | 56 | | | Response | | | | | | CR | 2 | 2.5% | 1 | 1.8% | | PR | 27 | 33.3% | 15 | 26.8% | | SD | 41 | 50.6% | 28 | 50.0% | | PD | 11 | 13.6% | 12 | 21.4% | | ORR | | | | | 0.377 | CR+PR | 29 | 35.8% | 16 | 28.6% | | SD+PD | 52 | 64.2% | 40 | 71.4% | | DCR | | | | | 0.229 | CR+PR+SD | 70 | 86.4% | 44 | 78.6% | | PD | 11 | 13.6% | 12 | 21.4% | |
|
|